Supporting the role of Dies1 as an immune-response regulator, Le Mercier et al. have also shown that Dies1 blockade, using a monoclonal antibody, caused an increase in tumour-infiltrating T-cells and decreased tumour growth, in an inducible melanoma transgenic mouse model6. Here, VSIR is linked to melanoma.